Implementation Guide CH VACD
5.0.0-ballot - ballot
This page is part of the CH VACD (R4) (v5.0.0-ballot: STU 5 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Id: RDB01-Composition
Identifier: urn:ietf:rfc:3986#urn:uuid:df06d24d-2f22-4315-a610-b780539fb627
Status: Final
Code: Immunization record (http://snomed.info/sct#41000179103)
Patient: Patient/TC-patient Wegmueller Monika
Date: December 10, 2021
Authors:
Patient/TC-patient Wegmueller Monika |
Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005)
Sections:
Immunization Administration |
Allergies |
Code: Hx of Immunization (http://loinc.org#11369-6)
Entries:
Immunization/TCB01-IMMUN1 |
Immunization/TCB01-IMMUN2 |
Code: Allergies and adverse reactions Document (http://loinc.org#48765-2)
Entries:
AllergyIntolerance/TCB01-ALLINTO1 |
2. http://test.fhir.ch/r4/Patient/TC-patient (Patient/TC-patient)
Anonymous Patient Female, DoB: 1967-02-10 ( Medical record number: 12345678)
3. http://test.fhir.ch/r4/Practitioner/TC-HCP1-C1 (Practitioner/TC-HCP1-C1)
Generated Narrative: Practitioner
ResourcePractitioner "TC-HCP1-C1"
Profile: CH Core Practitioner EPR
identifier: GLN/7601888888884
active: true
name: Peter Müller
telecom: ph: tel:+41.32.234.55.66(WORK), fax: fax:+41.32.234.55.67(WORK), mailto:allzeit.bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch
address: Grabenstrasse 2 Zürich 8005 CH
4. http://test.fhir.ch/r4/Organization/TC-ORG1 (Organization/TC-ORG1)
Generated Narrative: Organization
ResourceOrganization "TC-ORG1"
Profile: CH Core Organization EPR
identifier: GLN/7601777777718
name: Gruppenpraxis Müller
Contacts
Telecom Address ph: tel:+41.32.234.55.66(WORK), fax: fax:+41.32.234.55.67(WORK), mailto:bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch Grabenstrasse 2 Zürich ZH 8005 CH
5. http://test.fhir.ch/r4/PractitionerRole/TC-HCP1-ORG1-ROLE-performer (PractitionerRole/TC-HCP1-ORG1-ROLE-performer)
Generated Narrative: PractitionerRole
ResourcePractitionerRole "TC-HCP1-ORG1-ROLE-performer"
Profile: CH Core PractitionerRole EPR
active: true
practitioner: See on this page: Practitioner/TC-HCP1-C1
organization: See on this page: Organization/TC-ORG1
6. http://test.fhir.ch/r4/PractitionerRole/TC-HCP1-ORG1-ROLE-author (PractitionerRole/TC-HCP1-ORG1-ROLE-author)
Generated Narrative: PractitionerRole
ResourcePractitionerRole "TC-HCP1-ORG1-ROLE-author"
Profile: CH Core PractitionerRole EPR
active: true
practitioner: See on this page: Practitioner/TC-HCP1-C1
organization: See on this page: Organization/TC-ORG1
7. http://test.fhir.ch/r4/Immunization/TCB01-IMMUN1 (Immunization/TCB01-IMMUN1)
Generated Narrative: Immunization
ResourceImmunization "TCB01-IMMUN1"
Profile: CH VACD Immunization
Author of the content: See on this page: PractitionerRole/TC-HCP1-ORG1-ROLE-author
CH VACD Extension Immunization Medication Reference: See on this page: Medication/TC-IMMUN-MEDIC-FSMEIMMCC
identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/urn:uuid:4386ca26-6866-4322-a203-b488b84ab499status: COMPLETED
vaccineCode: FSME-Immun CC (CH VACD Swissmedic Authorized Vaccines#450)
lotNumber: 12-34244
patient: See on this page: Patient/TC-patient
occurrence: 2021-06-22
route: Intramuscular use (standardterms.edqm.eu#20035000)
Performers
Actor See on this page: PractitionerRole/TC-HCP1-ORG1-ROLE-performer ProtocolApplieds
TargetDisease Tickborne encephalitis (SNOWMED CT#712986001)
8. http://test.fhir.ch/r4/Medication/TC-IMMUN-MEDIC-FSMEIMMCC (Medication/TC-IMMUN-MEDIC-FSMEIMMCC)
Generated Narrative: Medication
ResourceMedication "TC-IMMUN-MEDIC-FSMEIMMCC"
Profile: CH VACD Medication For Immunization
identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/01194ac7-70ad-4259-b5f4-c5ff0c1b40c5code: FSME-IMMUN CC Inj Susp sep Nadel (unknown#7680004500039)
status: ACTIVE
ingredient
Batches
LotNumber VNR1T10C
9. http://test.fhir.ch/r4/Organization/TC-ORG-PFIZER (Organization/TC-ORG-PFIZER)
Generated Narrative: Organization
ResourceOrganization "TC-ORG-PFIZER"
Profile: CH Core Organization
identifier: GLN/7601001010604
name: Pfizer AG
Contacts
Telecom Address ph: tel:+41 800 562 825(WORK), fax: fax:+41 44 583 07 00(WORK), mailto:customer.ch@pfizer.com, https://www.pfizer.ch Schärenmoosstrasse 99 Postfach Zürich ZH 8052 CH
10. http://test.fhir.ch/r4/Immunization/TCB01-IMMUN2 (Immunization/TCB01-IMMUN2)
Generated Narrative: Immunization
ResourceImmunization "TCB01-IMMUN2"
Profile: CH VACD Immunization
Author of the content: See on this page: PractitionerRole/TC-HCP1-ORG1-ROLE-author
CH VACD Extension Immunization Medication Reference: See on this page: Medication/TC-IMMUN-MEDIC-BOOSTRIX
identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/urn:uuid:ebcf6de2-ed9c-463c-8b08-cb487af8ce4estatus: COMPLETED
vaccineCode: Boostrix (CH VACD Swissmedic Authorized Vaccines#637)
lotNumber: AHAVB946A
patient: See on this page: Patient/TC-patient
occurrence: 2020-12-09
route: Intramuscular use (standardterms.edqm.eu#20035000)
Performers
Actor See on this page: PractitionerRole/TC-HCP1-ORG1-ROLE-performer ProtocolApplieds
TargetDisease Tetanus (disorder) (SNOWMED CT#76902006), Pertussis (disorder) (SNOWMED CT#27836007), Diphtheria caused by Corynebacterium diphtheriae (disorder) (SNOWMED CT#397430003)
11. http://test.fhir.ch/r4/Medication/TC-IMMUN-MEDIC-BOOSTRIX (Medication/TC-IMMUN-MEDIC-BOOSTRIX)
Generated Narrative: Medication
ResourceMedication "TC-IMMUN-MEDIC-BOOSTRIX"
Profile: CH VACD Medication For Immunization
identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/ead68e47-34a6-4534-a658-b718e565fb91code: BOOSTRIX Inj Susp (unknown#7680006370012)
status: ACTIVE
ingredient
Batches
LotNumber AHAVB946A
12. http://test.fhir.ch/r4/Organization/TC-ORG-GSK (Organization/TC-ORG-GSK)
Generated Narrative: Organization
ResourceOrganization "TC-ORG-GSK"
Profile: CH Core Organization
identifier: GLN/7601001000674
name: GlaxoSmithKline AG
Contacts
Telecom Address ph: tel:+41 31 862 21 11(WORK), fax: fax:+41 31 862 22 00(WORK), mailto:swiss.info@gsk.com, https://www.gsk.com Talstrasse 3-5 Münchenbuchsee BE 3053 CH
13. http://test.fhir.ch/r4/AllergyIntolerance/TCB01-ALLINTO1 (AllergyIntolerance/TCB01-ALLINTO1)
Generated Narrative: AllergyIntolerance
ResourceAllergyIntolerance "TCB01-ALLINTO1"
Profile: CH VACD AllergyIntolerance
identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.2
/00476f5f-f3b7-4e49-9b52-5ec88d65c18eclinicalStatus: Active (AllergyIntolerance Clinical Status Codes#active)
verificationStatus: Confirmed (AllergyIntolerance Verification Status#confirmed)
code: Adverse reaction to component of vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (disorder) (SNOWMED CT#293122006)
patient: See on this page: Patient/TC-patient
onset: 2021-10-06
recordedDate: 2021-10-06
lastOccurrence: 2021-10-06